BSBenjamin M. Scott

Benjamin M. Scott

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Benjamin M. Scott has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • When DNA Writing is Free: Open Tools and Strategies to Accelerate the Bioeconomy

    by Benjamin Scott, Scott Pownall

    DNA synthesis and assembly techniques have enabled the creation of validated and standardized DNA parts, used for producing proteins, enzymes, and small molecules. However, most DNA parts are governed by material transfer agreements, which restrict sharing and reuse for commercial purposes even in the absence of patents, bottlenecking innovation. DNA synthesis, crucial for producing new parts, also remains expensive and therefore inaccessible to most researchers. With the breakneck pace of digital innovations for designing and learning from biology, a new and more open approach to the physical building and testing of biology is needed. We propose the establishment of an Open Bio Research Alliance, to create and distribute open collections of DNA and other biological parts, combined with regulated and affordable DNA synthesis services. Focusing on Canada’s bioeconomy, establishing domestic DNA synthesis infrastructure would not only secure global competitiveness in engineering biology, but also safeguard biosecurity and national sovereignty over critical resources. By harnessing and supporting existing lab automation resources, the Alliance will also help scale the building and testing of engineered biological systems. Leveraging these tools and strategies, Canada is well-positioned to lead the world in open and innovative biotechnology, paving the way for a thriving bioeconomy.

  • Open Access

    Automation Protocol for High-Efficiency and High-Quality Genomic DNA Extraction from Saccharomyces Cerevisiae v4

    by Nina Alperovich, David Ross, Benjamin M Scott

    Here, we describe a protocol for automated extraction of genomic DNA (gDNA) from yeast liquid culture and colonies. The protocol uses a Hamilton NGS-STAR automated liquid handler equipped with thermal-regulated microplate shakers. We have tested this automated protocol with 1.5 mL aliquots of liquid culture (OD600= 1) to demonstrate that it can provide high-quality gDNA at high efficiency. The protocol can also be implemented with manual pipetting, and/or to extract gDNA from larger volumes of culture by proportionally increasing the volumes of reagents and using an appropriate magnet separation rack. Thelast stepin this version contains a supplemental video with extra context and tips, as part of the protocols.io Spotlight series, featuring conversations with protocol authors.

  • Open Access

    Automation protocol for high-efficiency and high-quality genomic DNA extraction from Saccharomyces cerevisiae

    by Nina Alperovich, Benjamin M. Scott, David Ross

    Although many protocols have been previously developed for genomic DNA (gDNA) extraction from S. cerevisiae, to take advantage of recent advances in laboratory automation and DNA-barcode sequencing, there is a need for automated methods that can provide high-quality gDNA at high efficiency. Here, we describe and demonstrate a fully automated protocol that includes five basic steps: cell wall and RNA digestion, cell lysis, DNA binding to magnetic beads, washing with ethanol, and elution. Our protocol avoids the use of hazardous reagents (e.g., phenol, chloroform), glass beads for mechanical cell disruption, or incubation of samples at 100°C (i.e., boiling). We show that our protocol can extract gDNA with high efficiency both from cells grown in liquid culture and from colonies grown on agar plates. We also show results from gel electrophoresis that demonstrate that the resulting gDNA is of high quality.


  • Open Access

    Automation Protocol for High-Efficiency and High-Quality Genomic DNA Extraction from Saccharomyces Cerevisiae v3

    by Nina Alperovich, David Ross, Benjamin M Scott

    Here, we describe a protocol for automated extraction of genomic DNA (gDNA) from yeast liquid culture and colonies. The protocol uses a Hamilton NGS-STAR automated liquid handler equipped with thermal-regulated microplate shakers. We have tested this automated protocol with 1.5 mL aliquots of liquid culture (OD600= 1) to demonstrate that it can provide high-quality gDNA at high efficiency. The protocol can also be implemented with manual pipetting, and/or to extract gDNA from larger volumes of culture by proportionally increasing the volumes of reagents and using an appropriate magnet separation rack.

  • Engineering the gut microbiome

    by Xiaowu Bai, Ziyu Huang, Anna M. Duraj-Thatte, Matthias P. Ebert, Fen Zhang, Elke Burgermeister, Xue Liu, Benjamin M. Scott, Guoxin Li, Tao Zuo


  • Open Access

    Automation Protocol for High-Efficiency and High-Quality Genomic DNA Extraction from Saccharomyces Cerevisiae v2

    by Nina Alperovich, David Ross, Benjamin M Scott

    Here, we describe a protocol for automated extraction of genomic DNA (gDNA) from yeast liquid culture and colonies. The protocol uses a Hamilton NGS-STAR automated liquid handler equipped with thermal-regulated microplate shakers. We have tested this automated protocol with 1.5 mL aliquots of liquid culture (OD600= 1) to demonstrate that it can provide high-quality gDNA at high efficiency. The protocol can also be implemented with manual pipetting, and/or to extract gDNA from larger volumes of culture by proportionally increasing the volumes of reagents and using an appropriate magnet separation rack.

  • Open Access

    Automation Protocol for High-Efficiency and High-Quality Genomic DNA Extraction from Saccharomyces Cerevisiae v1

    by Nina Alperovich, David Ross, Benjamin Scott

    Here, we describe a protocol for automated extraction of genomic DNA (gDNA) from yeast liquid culture and colonies. The protocol uses a Hamilton NGS-STAR automated liquid handler equipped with thermal-regulated microplate shakers. We have tested this automated protocol with 1.5 mL aliquots of liquid culture (OD600= 1) to demonstrate that it can provide high-quality gDNA at high efficiency. The protocol can also be implemented with manual pipetting, and/or to extract gDNA from larger volumes of culture by proportionally increasing the volumes of reagents and using an appropriate magnet separation rack.

  • Top Cited Papers

    Self-tunable engineered yeast probiotics for the treatment of inflammatory bowel disease

    by Benjamin M. Scott, Cristina Gutiérrez-Vázquez, Liliana M. Sanmarco, Jessica A. da Silva Pereira, Zhaorong Li, Agustín Plasencia, Patrick Hewson, Laura M. Cox, Madelynn O’brien, Steven K. Chen, et al.

    Inflammatory bowel disease (IBD) is a complex chronic inflammatory disorder of the gastrointestinal tract. Extracellular adenosine triphosphate (eATP) produced by the commensal microbiota and host cells activates purinergic signaling, promoting intestinal inflammation and pathology. Based on the role of eATP in intestinal inflammation, we developed yeast-based engineered probiotics that express a human P2Y2 purinergic receptor with up to a 1,000-fold increase in eATP sensitivity. We linked the activation of this engineered P2Y2 receptor to the secretion of the ATP-degrading enzyme apyrase, thus creating engineered yeast probiotics capable of sensing a pro-inflammatory molecule and generating a proportional self-regulated response aimed at its neutralization. These self-tunable yeast probiotics suppressed intestinal inflammation in mouse models of IBD, reducing intestinal fibrosis and dysbiosis with an efficacy similar to or higher than that of standard-of-care therapies usually associated with notable adverse events. By combining directed evolution and synthetic gene circuits, we developed a unique self-modulatory platform for the treatment of IBD and potentially other inflammation-driven pathologies.


  • Open Access

    Predicted Coronavirus Nsp5 Protease Cleavage Sites in the Human Proteome: A Resource for SARS-CoV-2 Research

    by Benjamin M. Scott, Vincent Lacasse, Ditte G. Blom, Peter D. Tonner, Nikolaj S. Blom

    Background: The coronavirus nonstructural protein 5 (Nsp5) is a cysteine protease required for processing the viral polyprotein and is therefore crucial for viral replication. Nsp5 from several coronaviruses have also been found to cleave host proteins, disrupting molecular pathways involved in innate immunity. Nsp5 from the recently emerged SARS-CoV-2 virus interacts with and can cleave human proteins, which may be relevant to the pathogenesis of COVID-19. Based on the continuing global pandemic, and emerging understanding of coronavirus Nsp5-human protein interactions, we set out to predict what human proteins are cleaved by the coronavirus Nsp5 protease using a bioinformatics approach. Results: Using a previously developed neural network trained on coronavirus Nsp5 cleavage sites (NetCorona), we made predictions of Nsp5 cleavage sites in all human proteins. Structures of human proteins in the Protein Data Bank containing a predicted Nsp5 cleavage site were then examined, generating a list of 92 human proteins with a highly predicted and accessible cleavage site. Of those, 48 are expected to be found in the same cellular compartment as Nsp5. Analysis of this targeted list of proteins revealed molecular pathways susceptible to Nsp5 cleavage and therefore relevant to coronavirus infection, including pathways involved in mRNA processing, cytokine response, cytoskeleton organization, and apoptosis. Conclusions: This study combines predictions of Nsp5 cleavage sites in human proteins with protein structure information and protein network analysis. We predicted cleavage sites in proteins recently shown to be cleaved in vitro by SARS-CoV-2 Nsp5, and we discuss how other potentially cleaved proteins may be relevant to coronavirus mediated immune dysregulation. The data presented here will assist in the design of more targeted experiments, to determine the role of coronavirus Nsp5 cleavage of host proteins, which is relevant to understanding the molecular pathology of SARS-CoV-2 infection.